These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 8558198)

  • 61. del(15q) is a recurrent minor-route cytogenetic abnormality in the clonal evolution of chronic myelogenous leukemia.
    Yin CC; Abruzzo LV; Qiu X; Apostolidou E; Cortes JE; Medeiros LJ; Lu G
    Cancer Genet Cytogenet; 2009 Jul; 192(1):18-23. PubMed ID: 19480932
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Risk stratification of chromosomal abnormalities in chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy.
    Wang W; Cortes JE; Tang G; Khoury JD; Wang S; Bueso-Ramos CE; DiGiuseppe JA; Chen Z; Kantarjian HM; Medeiros LJ; Hu S
    Blood; 2016 Jun; 127(22):2742-50. PubMed ID: 27006386
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Unusual cytogenetic evolution in CML treated with interferon-alpha.
    Maloisel F; Laplace A; Uettwiller F; Lioure B; Oberling F
    Leukemia; 1997 Jun; 11(6):893-4. PubMed ID: 9177448
    [No Abstract]   [Full Text] [Related]  

  • 64. Application of FISH to complex chromosomal rearrangements associated with chronic myelogenous leukemia.
    Sullivan BA; Schiffer CA; Patil SR; Hulseberg D; Leana-Cox J; Schwartz S
    Cancer Genet Cytogenet; 1995 Jul; 82(2):93-9. PubMed ID: 7664251
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Chronic myeloid leukemia associated hypereosinophilic syndrome with a clonal t(4;7)(q11;q32).
    Duell T; Mittermüller J; Schmetzer HM; Kolb HJ; Wilmanns W
    Cancer Genet Cytogenet; 1997 Apr; 94(2):91-4. PubMed ID: 9109934
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Clinical Significance of Additional Chromosomal 8 Clonal Evolution in CML Progression].
    Ji O; Zhu GR; Lin L; Wu Y; Ji JM; Yu H; Shen Q
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Dec; 26(6):1598-1603. PubMed ID: 30501690
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Clonal chromosomal abnormalities appearing in Philadelphia chromosome-negative metaphases during CML treatment.
    Issa GC; Kantarjian HM; Gonzalez GN; Borthakur G; Tang G; Wierda W; Sasaki K; Short NJ; Ravandi F; Kadia T; Patel K; Luthra R; Ferrajoli A; Garcia-Manero G; Rios MB; Dellasala S; Jabbour E; Cortes JE
    Blood; 2017 Nov; 130(19):2084-2091. PubMed ID: 28835440
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Proposal for a simple synthesis prognostic staging system in chronic myelogenous leukemia.
    Kantarjian HM; Keating MJ; Smith TL; Talpaz M; McCredie KB
    Am J Med; 1990 Jan; 88(1):1-8. PubMed ID: 2294759
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Ring chromosomes in chronic myelogenous leukemia: an ominous finding.
    Lewis JP; Jenks H; Walling P
    Leuk Res; 1988; 12(5):379-83. PubMed ID: 3288814
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cytogenetics of chronic myelogenous leukemia.
    Bernstein R
    Semin Hematol; 1988 Jan; 25(1):20-34. PubMed ID: 3279513
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Clinical and prognostic features of patients with Philadelphia chromosome-positive chronic myelogenous leukemia and extramedullary disease.
    Terjanian T; Kantarjian H; Keating M; Talpaz M; McCredie K; Freireich EJ
    Cancer; 1987 Jan; 59(2):297-300. PubMed ID: 3467820
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Determinants of prognosis in late chronic-phase chronic myelogenous leukemia.
    Rodriguez J; Cortes J; Smith T; O'Brien S; Rios MB; Talpaz M; Kantarjian H
    J Clin Oncol; 1998 Dec; 16(12):3782-7. PubMed ID: 9850022
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Prognostic significance of loss of a chromosome 17p and p53 gene mutations in blast crisis of chronic myelogenous leukaemia.
    Nakai H; Misawa S; Taniwaki M; Horiike S; Takashima T; Seriu T; Nakagawa H; Fujii H; Shimazaki C; Maruo N
    Br J Haematol; 1994 Jun; 87(2):425-7. PubMed ID: 7947294
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Occurrence of chromosomal abnormalities in Philadelphia chromosome-negative metaphases in patients with chronic-phase chronic myeloid leukemia undergoing TKI treatments.
    Sheng G; Xue M; Wang Q; Wen L; Chen S; Zhang X; Yang X
    Leuk Lymphoma; 2019 Dec; 60(14):3503-3511. PubMed ID: 31282805
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Chronic myelogenous leukemia in blast crisis: retrospective analysis of prognostic factors in 90 patients.
    Griesshammer M; Heinze B; Hellmann A; Popp C; Anger B; Heil G; Bangerter M; Heimpel H
    Ann Hematol; 1996 Nov; 73(5):225-30. PubMed ID: 8959940
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A new prognostic score for survival of patients with chronic myeloid leukemia treated with interferon alfa. Writing Committee for the Collaborative CML Prognostic Factors Project Group.
    Hasford J; Pfirrmann M; Hehlmann R; Allan NC; Baccarani M; Kluin-Nelemans JC; Alimena G; Steegmann JL; Ansari H
    J Natl Cancer Inst; 1998 Jun; 90(11):850-8. PubMed ID: 9625174
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Chromosome 17 abnormalities and inactivation of the p53 gene in chronic myeloid leukemia and their prognostic significance.
    Nakai H; Misawa S
    Leuk Lymphoma; 1995 Oct; 19(3-4):213-21. PubMed ID: 8535212
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Prognostic significance of additional cytogenetic abnormalities at diagnosis of Philadelphia chromosome-positive chronic granulocytic leukemia.
    Sokal JE; Gomez GA; Baccarani M; Tura S; Clarkson BD; Cervantes F; Rozman C; Carbonell F; Anger B; Heimpel H
    Blood; 1988 Jul; 72(1):294-8. PubMed ID: 3164637
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Origin of near-haploidy in malignant hematopoietic cells.
    Verma RS; Macera MJ; Silver RT; Coleman M
    Leuk Res; 1988; 12(11-12):941-50. PubMed ID: 3216674
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Therapeutic and prognostic value of modal number of chromosomes at the blastic phase of Philadelphia-chromosome-positive chronic myeloid leukemia: comparison based on the same criteria between Nagasaki University and Roswell Park Memorial Institute.
    Sadamori N; Yao E; Mine M; Tokunaga S; Matsunaga M; Nakamura H; Sasagawa I; Itoyama T; Hayashibara T; Sandberg AA
    Acta Haematol; 1992; 87(1-2):49-53. PubMed ID: 1585770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.